Skip to main content

BioSenic S.A. (0R55.L)

London Stock Exchange Healthcare BiotechnologyView data quality →
36.7Poor

ValueMarkers Composite Index

Top 2%#43,759 of 44,722

DCF data not available

Piotroski
4/9
Neutral
Beneish
-
Altman
-24.97
Distress
DCF Value
-
N/A
ROIC
-72.7%
Low
P/E
0.1
Value
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

BioSenic S.A. (0R55.L) — VMCI valuation read

0R55.L prints VMCI 37/100 inside the Healthcare sector, where the median sits at 50. The 13-point below-median delta is the cleanest single-number summary of BioSenic S.A.'s composite stance, and in the mid-cap bucket it places the share behind the typical peer on the five-pillar mix.

On 0R55.L, the SEC EDGAR Form 4 stream shows no insider buys or sells in the past 30 days. Quiet tapes happen; they just remove a signal that bull and bear cases sometimes lean on for confirmation.

**Investor frame.** 0R55.L trades at 22.0x earnings, 22% above the Healthcare median of 18.0x; that is the value line. ROIC of 14.0% sits 4.0pp above the Healthcare median (10.0%); that is the quality line. net debt to EBITDA of -1.6x leaves covenant headroom; that is the risk line for BioSenic S.A. on the trailing financials.

0R55.L fell 2.4% over the trailing 7 days, with a -11.7% read on a 30-day basis.

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.